AAAAAA
Results: 1-25/54
Authors:
De Clercq, E
Andrei, G
Snoeck, R
De Bolle, L
Naesens, L
Degreve, B
Balzarini, J
Zhang, Y
Schols, D
Leyssen, P
Ying, C
Neyts, J
Citation: E. De Clercq et al., Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents, NUCLEOS NUC, 20(4-7), 2001, pp. 271-285
Authors:
McGuigan, C
Barucki, H
Carangio, A
Blewett, S
Srinivasan, S
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: C. Mcguigan et al., Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents, NUCLEOS NUC, 20(4-7), 2001, pp. 287-296
Authors:
Carangio, A
McGuigan, C
Cahard, D
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: A. Carangio et al., Synthesis and in vitro evaluation of novel anti-varicella-zoster virus (VZV) nucleosides, NUCLEOS NUC, 20(4-7), 2001, pp. 653-656
Authors:
Wang, J
Froeyen, M
Hendrix, C
Andrei, C
Snoeck, R
Lescrinier, E
De Clercq, E
Herdewijn, P
Citation: J. Wang et al., (D)- and (L)-cyclohexenyl-G, a new class of antiviral agents: Synthesis, conformational analysis, molecular modeling, and biological activity, NUCLEOS NUC, 20(4-7), 2001, pp. 727-730
Authors:
Srinivasan, S
McGuigan, C
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: S. Srinivasan et al., Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): Effect of terminal unsaturation in the side-chain, NUCLEOS NUC, 20(4-7), 2001, pp. 763-766
Authors:
Blewett, S
McGuigan, C
Barucki, H
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: S. Blewett et al., Bicyclic furo pyrimidine nucleosides with aryloxyphenyl and halophenyl substituted side chains as potent and selective Varicella-Zoster Virus inhibitors, NUCLEOS NUC, 20(4-7), 2001, pp. 1063-1066
Authors:
Ziegler, JL
Simonart, T
Snoeck, R
Citation: Jl. Ziegler et al., Kaposi's sarcoma, oncogenic viruses, and iron, J CLIN VIRO, 20(3), 2001, pp. 127-130
Authors:
Snoeck, R
Bossens, M
Parent, D
Delaere, B
Degreef, H
Van Ranst, M
Noel, JC
Wulfsohn, MS
Rooney, JF
Jaffe, HS
De Clercq, E
Citation: R. Snoeck et al., Phase II double-blind, placebo-controlled study of the safety and efficacyof cidofovir topical gel for the treatment of patients with human papillomavirus infection, CLIN INF D, 33(5), 2001, pp. 597-602
Authors:
Van Valckenborgh, I
Wellens, W
De Boeck, K
Snoeck, R
De Clercq, E
Feenstra, L
Citation: I. Van Valckenborgh et al., Systemic cidofovir in papillomatosis, CLIN INF D, 32(3), 2001, pp. E62-E64
Authors:
Stephens, CE
Felder, TM
Sowell, JW
Andrei, G
Balzarini, J
Snoeck, R
De Clercq, E
Citation: Ce. Stephens et al., Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones, BIO MED CH, 9(5), 2001, pp. 1123-1132
Authors:
Andrei, G
Snoeck, R
Schols, D
De Clercq, E
Citation: G. Andrei et al., Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positivecells, ONCOL RES, 12(9-10), 2001, pp. 397-408
Authors:
Srinivasan, S
McGuigan, C
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: S. Srinivasan et al., Bicyclic nucleoside inhibitors of Varicella-Zoster virus (VZV): The effectof terminal unsaturation in the side chain, BIOORG MED, 11(3), 2001, pp. 391-393
Authors:
Brancale, A
McGuigan, C
Algain, B
Savy, P
Benhida, R
Fourrey, JL
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: A. Brancale et al., Bicyclic anti-VZV nucleosides: Thieno analogues retain full antiviral activity, BIOORG MED, 11(18), 2001, pp. 2507-2510
Authors:
Geerinck, K
Lukito, G
Snoeck, R
De Vos, R
De Clercq, E
Vanrenterghem, Y
Degreef, H
Maes, B
Citation: K. Geerinck et al., A case of human orf in an immunocompromised patient treated successfully with cidofovir cream, J MED VIROL, 64(4), 2001, pp. 543-549
Authors:
Koonsaeng, S
Verschraegen, C
Freedman, R
Bossens, M
Kudelka, A
Kavanagh, J
Sittisomwong, T
DeClercq, E
Snoeck, R
Citation: S. Koonsaeng et al., Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir, J MED VIROL, 64(2), 2001, pp. 195-198
Authors:
Chaouni-Benabdallah, A
Galtier, C
Allouchi, H
Kherbeche, A
Chavignon, O
Teulade, JC
Witvrouw, M
Pannecouque, C
Snoeck, R
Andrei, G
Balzarini, J
De Clercq, E
Fauvelle, F
Enguehard, C
Gueiffier, A
Citation: A. Chaouni-benabdallah et al., 3-benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agents, CHEM PHARM, 49(12), 2001, pp. 1631-1635
Authors:
Mavel, S
Renou, JL
Galtier, C
Snoeck, R
Andrei, G
Balzarini, J
De Clercq, E
Gueiffier, A
Citation: S. Mavel et al., Synthesis of imidazo[1,2-a] pyridine derivatives as antiviral agents, ARZNEI-FOR, 51(4), 2001, pp. 304-309
Authors:
Snoeck, R
Van Laethem, Y
De Clercq, E
De Maubeuge, J
Clumeck, N
Citation: R. Snoeck et al., Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome, ARCH IN MED, 161(19), 2001, pp. 2382-2384
Authors:
Preiser, W
Kapur, N
Snoeck, R
Groves, RW
Brink, NS
Citation: W. Preiser et al., No apparent effect of cidofovir in epidermodysplasia verruciformis, J CLIN VIRO, 16(1), 2000, pp. 55-57
Authors:
Snoeck, R
Andrei, G
De Clercq, E
Citation: R. Snoeck et al., Novel agents for the therapy of varicella-zoster virus infections, EXPERT OP I, 9(8), 2000, pp. 1743-1751
Authors:
Brancale, A
McGuigan, C
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: A. Brancale et al., Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): The effectof a terminal halogen substitution in the side-chain, BIOORG MED, 10(11), 2000, pp. 1215-1217
Authors:
Brancale, A
Srinivasan, S
McGuigan, C
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: A. Brancale et al., Synthesis and anti-varicella-zoster virus activity of some novel bicyclic nucleoside inhibitors: effect of enhanced aqueous solubility, ANTIVIR CHE, 11(6), 2000, pp. 383-393
Authors:
McGuigan, C
Pathirana, RN
Jones, G
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: C. Mcguigan et al., Anti-varicella-zoster virus bicyclic nucleosides: replacement of furo by pyrro base reduces antiviral potency, ANTIVIR CHE, 11(5), 2000, pp. 343-348
Authors:
Martinez, A
Esteban, A
Castro, A
Gil, C
Conde, S
Andrei, G
Snoeck, R
Balzarini, J
De Clercq, E
Citation: A. Martinez et al., Thienothiadiazine 2,2-dioxide acyclonucleosides: synthesis and antiviral activity, ANTIVIR CHE, 11(3), 2000, pp. 221-230
Authors:
Snoeck, R
Citation: R. Snoeck, Antiviral therapy of herpes simplex, INT J ANT A, 16(2), 2000, pp. 157-159